Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement-Reference-Cited by-同舟云学术

Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement

Published:2014-10 Issue: Volume:272 Page:93-99
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Alcaraz-Iborra Manuel,Carvajal Francisca,Lerma-Cabrera José Manuel,Valor Luis Miguel,Cubero Inmaculada

Funder

Ministerio de Economia y Competitividad (Spain)

CTS1350

FEDER UALM05-23-006

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference63 articles.

1. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior;Sakurai;Cell,1998

2. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity;de Lecea;Proc Natl Acad Sci,1998

3. Orexins (hypocretins) directly excite tuberomammillary neurons;Bayer;Eur J Neurosci,2001

4. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity;Cason;Physiol Behav,2010

5. Distribution of orexin neurons in the adult rat brain;Nambu;Brain Res,1999

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orexin-mediated motivated arousal and reward seeking;Peptides;2024-10

2. Sex-dimorphic functions of orexin in neuropsychiatric disorders;Heliyon;2024-08

3. An animal model for the study of binge-like eating episodes preceded by frustration events in females and non-food deprived animals;Learning and Motivation;2024-05

4. Evaluating the efficacy of the selective orexin 1 receptor antagonist nivasorexant in an animal model of binge‐eating disorder;International Journal of Eating Disorders;2024-03-08

5. Efficacy, safety, and tolerability of nivasorexant in adults with binge‐eating disorder: A randomized, Phase II proof of concept trial;International Journal of Eating Disorders;2023-08-16